文献速递心血管CT

冠状动脉周围脂肪衰减指数对冠心病预后价值的系统综述与荟萃分析

Pericoronary fat attenuation index is a potential indicator for the prognosis of coronary heart disease: a systematic review and meta-analysis.
PubMed 文献 · Clin Radiol · 2026-03-12

结果显示,较高的FAI对MACE具有增量预后价值(前瞻性随访研究HR=3.28,95%CI 2.03-5.32,P<0.001,I²=81%),且易损斑块FAI较稳定斑块平均高7.81 HU(95%CI 4.65-10.97,I²=85%)。FAI有望作为检测冠状动脉炎症、识别易损斑块和预测MACE的指标。

要点

  • 高FAI与MACE风险升高相关,前瞻性研究HR=3.28(95%CI 2.03-5.32)。
  • 易损斑块FAI较稳定斑块平均高7.81 HU(95%CI 4.65-10.97)。
  • FAI对心脏死亡的HR=4.02但结果不稳健,动态FAI证据有限。

核心结论

  • 冠状动脉周围FAI是检测冠状动脉炎症、区分易损斑块与稳定斑块以及预测MACE的有前景指标。
  • 较高FAI对MACE具有增量预后价值,尤其在前瞻性随访研究中显著(HR=3.28)。
  • FAI在易损斑块中较稳定斑块显著升高,平均差7.81 HU。
  • 以心脏死亡为结局时HR增至4.02,但该发现不稳健。
  • 动态FAI变化可能有助于监测治疗反应,但当前证据不足以支持其作为冠状动脉抗炎干预的替代终点。

研究设计与样本

  • 研究类型为系统综述与荟萃分析,遵循PRISMA指南。
  • 检索PubMed、Cochrane library和Embase,检索词为「Epicardial Adipose Tissue」和「Tomography, X-Ray Computed」,截至2025年5月28日。
  • 由两名独立研究者提取数据并评估方法学质量。
  • 统计分析使用Review Manager 5.3和R 4.5.2。

诊断标准与关键数值

  • 前瞻性随访研究中,较高FAI预测MACE的HR=3.28(95%CI 2.03-5.32,P<0.001,I²=81%)。
  • FAI预测心脏死亡的HR=4.02(95%CI 1.26-12.88,P=0.02,I²=92%),但该发现不稳健。
  • 易损斑块与稳定斑块FAI平均差为7.81 HU(95%CI 4.65-10.97,I²=85%)。

临床应用与阅片要点

  • 在冠脉CTA阅片时,可关注冠状动脉周围脂肪组织的衰减指数(FAI),其升高提示冠状动脉炎症和易损斑块可能。
  • FAI可作为MACE风险分层的辅助指标,但需结合临床和其他影像特征综合判断。

局限性

  • 心脏死亡结局的HR结果不稳健。
  • 动态FAI变化监测治疗反应的证据有限,不足以支持作为替代终点。
  • 纳入研究间存在显著异质性(I²最高达92%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: The aim of this comprehensive updated systematic review and meta-analysis was to evaluate the prognostic value of the pericoronary fat attenuation index (FAI) for major adverse cardiovascular events (MACEs) and its ability to differentiate vulnerable from stable plaques.

MATERIALS AND METHODS: A comprehensive literature search was conducted in PubMed, the Cochrane library, and Embase with the search terms 'Epicardial Adipose Tissue' and 'Tomography, X-Ray Computed' until 28 May 2025. Data were extracted and methodological quality was assessed by two independent investigators according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Fifteen studies were included in this systematic review and meta-analysis. All statistical analyses were performed using Review Manager software, version 5.3 and R 4.5.2.

RESULTS: The results indicated that higher pericoronary FAI values provided incremental prognostic value for MACE in studies with prospective follow-up (hazard ratio [HR]=3.28, 95% confidence interval [CI]: 2.03 to 5.32, P<0.001, I2 = 81%). When specifically evaluating cardiac death as an outcome, the HR increased to 4.02 (95% CI: 1.26 to 12.88, P=0.02, I2 = 92%), but this finding was not robust. Furthermore, FAI demonstrated a statistically significant elevation in vulnerable plaques compared to stable plaques, exhibiting a mean difference of 7.81 Hounsfield units (95% CI: 4.65 to 10.97, I2 = 85%). Dynamic FAI changes may help monitor therapeutic responses, but current evidence is too limited to support FAI as a surrogate endpoint for coronary anti-inflammatory interventions.

CONCLUSION: These collective findings underscore the role of pericoronary FAI as a promising indicator for detecting coronary inflammation, distinguishing vulnerable plaques, and predicting MACE.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Long Q, Yu M, Xiong YY, et al. Pericoronary fat attenuation index is a potential indicator for the prognosis of coronary heart disease: a systematic review and meta-analysis. Clin Radiol. 2026. PMID: 41980471. doi:10.1016/j.crad.2026.107310

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。